BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37888637)

  • 1. Deep Brain Stimulation for Focal or Segmental Craniocervical Dystonia in Patients Who Have Failed Botulinum Neurotoxin Therapy-A Narrative Review of the Literature.
    Odorfer TM; Volkmann J
    Toxins (Basel); 2023 Oct; 15(10):. PubMed ID: 37888637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep brain stimulation for dystonia.
    Rodrigues FB; Duarte GS; Prescott D; Ferreira J; Costa J
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012405. PubMed ID: 30629283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Deep brain stimulation in the treatment of torticollis and Meige syndrome].
    Sobstyl M; Ząbek M
    Neurol Neurochir Pol; 2011; 45(6):590-9. PubMed ID: 22212990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue Subthalamic Deep Brain Stimulation for Refractory Meige Syndrome.
    Aragão VT; Barbosa Casagrande SC; Listik C; Teixeira MJ; Barbosa ER; Cury RG
    Stereotact Funct Neurosurg; 2021; 99(5):451-453. PubMed ID: 33895729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-voltage bilateral pallidal stimulation for severe meige syndrome in a patient with primary segmental dystonia: case report.
    Romito LM; Elia AE; Franzini A; Bugiani O; Albanese A
    Neurosurgery; 2010 Sep; 67(3 Suppl Operative):onsE308; discussion onsE308. PubMed ID: 20729656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral deep brain stimulation of the subthalamic nucleus in primary Meige syndrome.
    Zhan S; Sun F; Pan Y; Liu W; Huang P; Cao C; Zhang J; Li D; Sun B
    J Neurosurg; 2018 Mar; 128(3):897-902. PubMed ID: 28548593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review.
    Colosimo C; Tiple D; Berardelli A
    Neurotox Res; 2012 Nov; 22(4):265-73. PubMed ID: 22359151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arching deep brain stimulation in dystonia types.
    Kim HJ; Jeon B
    J Neural Transm (Vienna); 2021 Apr; 128(4):539-547. PubMed ID: 33740122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pallidal neurostimulation versus botulinum toxin injections in the treatment of cervical dystonia: protocol of a randomized, sham-controlled trial (StimTox-CD).
    Odorfer TM; Malzahn U; Matthies C; Heuschmann PU; Volkmann J
    Neurol Res Pract; 2019; 1():2. PubMed ID: 33324868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of pallidal stimulation for Meige syndrome.
    Horisawa S; Ochiai T; Goto S; Nakajima T; Takeda N; Kawamata T; Taira T
    J Neurosurg; 2018 Jan; 130(1):84-89. PubMed ID: 29350600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The barriers and facilitators to satisfaction with botulinum neurotoxin treatment in people with cervical dystonia: a systematic review.
    Boyce MJ; McCambridge AB; Bradnam LV; Canning CG; Verhagen AP
    Neurol Sci; 2022 Aug; 43(8):4663-4670. PubMed ID: 35593979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurophysiological Basis of Deep Brain Stimulation and Botulinum Neurotoxin Injection for Treating Oromandibular Dystonia.
    Maezawa H; Hirata M; Yoshida K
    Toxins (Basel); 2022 Nov; 14(11):. PubMed ID: 36356002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Efficacy of Deep Brain Stimulation of Bilateral Globus Pallidus Internus in Primary Meige Syndrome.
    Tian H; Yu Y; Zhen X; Zhang L; Yuan Y; Zhang B; Wang L
    Stereotact Funct Neurosurg; 2019; 97(5-6):356-361. PubMed ID: 31927550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum neurotoxins for the treatment of focal dystonias: Review of rating tools used in clinical trials.
    Del Sorbo F; Albanese A
    Toxicon; 2015 Dec; 107(Pt A):89-97. PubMed ID: 26365917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar Long-Term Clinical Outcomes of Deep Brain Stimulation With Different Electrode Targets for Primary Meige Syndrome: One Institution's Experience of 17 Cases.
    Tian H; Xiong NX; Xiong N; Liu XM; Rao J; Xiang W; Jiang XB; Zhao HY; Fu P
    Neuromodulation; 2021 Feb; 24(2):300-306. PubMed ID: 33159411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of deep brain stimulation for Meige syndrome.
    Lyons MK; Birch BD; Hillman RA; Boucher OK; Evidente VG
    Neurosurg Focus; 2010 Aug; 29(2):E5. PubMed ID: 20672922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral pallidal deep brain stimulation in primary Meige syndrome.
    Sako W; Morigaki R; Mizobuchi Y; Tsuzuki T; Ima H; Ushio Y; Nagahiro S; Kaji R; Goto S
    Parkinsonism Relat Disord; 2011 Feb; 17(2):123-5. PubMed ID: 21147544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical outcome of bilateral pallidal stimulation for intractable craniocervical dystonia (Meige syndrome). Report of 6 patients.
    Sobstyl M; Brzuszkiewicz-Kuźmicka G; Zaczyński A; Pasterski T; Aleksandrowicz M; Ząbek M
    J Neurol Sci; 2017 Dec; 383():153-157. PubMed ID: 29246604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset latency of segmental dystonia after deep brain stimulation cessation: a randomized, double-blind crossover trial.
    Levin J; Singh A; Feddersen B; Mehrkens JH; Bötzel K
    Mov Disord; 2014 Jun; 29(7):944-9. PubMed ID: 24375720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.